PepVax

PepVax is an early-stage biotechnology company developing a DNA-based drug delivery and development platform. Our novel DNA plasmid delivery system employs a simplified delivery method, and our "Trojan Horse" approach uses the patient's own cells to produce proteins, T-cells, and antibodies needed for cancer, infectious diseases, and genetic disorders within the body.